Skip to main content

Table 4 Annual drug utilisation

From: Real-world costs of autosomal dominant polycystic kidney disease in the Nordics

Proportion (%) of patients using drug class, past 12 months CKD 1–3 (n = 64) CKD 4–5 (n = 55) Dialysis (n = 61) Transplant (n = 63) P value
Antihypertensives 84 98 84 87 0.0275
Phosphate binders 0 21 95 14 <0.0001
ESAs 2 13 80 15 <0.0001
Analgesics for kidney paina 17 28 25 17 0.4149
Vitamin D analogsa 14 57 97 43 <0.0001
Immunosupressantsa 0 0 7 100 <0.0001
Other drugs 19 36 90 41 <0.0001
  1. P values calculated with Fisher’s exact test unless otherwise specified
  2. ESA Erythropoiesis-stimulating agent
  3. aχ2 test